IRIS Accounts Production v23.2.0.158 07700937 Board of Directors 1.1.22 31.12.22 31.12.22 false true false false true false ordinary A shares 1.00000 ordinary D shares 1.00000 ordinary E shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh077009372021-12-31077009372022-12-31077009372022-01-012022-12-31077009372020-12-31077009372021-01-012021-12-31077009372021-12-3107700937ns10:Originalns15:EnglandWales2022-01-012022-12-3107700937ns14:PoundSterlingns10:Original2022-01-012022-12-3107700937ns10:Originalns10:Director12022-01-012022-12-3107700937ns10:Original2022-01-012022-12-3107700937ns10:Original2022-12-3107700937ns10:Originalns10:PrivateLimitedCompanyLtd2022-01-012022-12-3107700937ns10:Originalns10:SmallEntities2022-01-012022-12-3107700937ns10:Originalns10:AuditExempt-NoAccountantsReport2022-01-012022-12-3107700937ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-01-012022-12-3107700937ns10:SmallCompaniesRegimeForAccountsns10:Original2022-01-012022-12-3107700937ns10:Originalns10:FullAccounts2022-01-012022-12-3107700937ns10:Originalns10:OrdinaryShareClass12022-01-012022-12-3107700937ns10:Originalns10:OrdinaryShareClass22022-01-012022-12-3107700937ns10:OrdinaryShareClass3ns10:Original2022-01-012022-12-3107700937ns10:Originalns10:Director22022-01-012022-12-3107700937ns10:Originalns10:Director32022-01-012022-12-3107700937ns10:Originalns10:RegisteredOffice2022-01-012022-12-3107700937ns10:Original2021-12-3107700937ns10:Originalns5:CurrentFinancialInstruments2022-12-3107700937ns10:Originalns5:CurrentFinancialInstruments2021-12-3107700937ns5:ShareCapitalns10:Original2022-12-3107700937ns5:ShareCapitalns10:Original2021-12-3107700937ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3107700937ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-12-3107700937ns10:Originalns5:PlantMachinery2022-01-012022-12-3107700937ns10:Original2021-01-012021-12-3107700937ns10:Originalns5:PlantMachinery2021-12-3107700937ns10:Originalns5:PlantMachinery2022-12-3107700937ns10:Originalns5:PlantMachinery2021-12-3107700937ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3107700937ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2021-12-3107700937ns10:Originalns10:OrdinaryShareClass12022-12-3107700937ns10:Originalns10:OrdinaryShareClass22022-12-3107700937ns10:OrdinaryShareClass3ns10:Original2022-12-31
REGISTERED NUMBER: 07700937 (England and Wales)






















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2022

FOR

GLAN YR AFON SURGERY LTD

GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022










Page

Company information 1

Balance sheet 2

Notes to the financial statements 4


GLAN YR AFON SURGERY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2022







DIRECTORS: Dr K G Syal
Dr G Mathews
Dr A Samarasinghe





REGISTERED OFFICE: Glan Yr Afon Surgery
Shop Row
Tredegar
NP22 4LB





REGISTERED NUMBER: 07700937 (England and Wales)





ACCOUNTANTS: MHA (trading name of MacIntyre Hudson LLP,
a limited liability partnership in England
and Wales (Registered number OC3123))
Elfed House
Oak Tree Court
Cardiff Gate Business Park
Cardiff
CF23 8RS

GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937)

BALANCE SHEET
31 DECEMBER 2022

2022 2021
Notes £    £   
FIXED ASSETS
Tangible assets 4 1,056 1,282

CURRENT ASSETS
Debtors 5 87,524 83,114
Cash at bank 110,993 86,978
198,517 170,092
CREDITORS
Amounts falling due within one year 6 (150,466 ) (127,358 )
NET CURRENT ASSETS 48,051 42,734
TOTAL ASSETS LESS CURRENT
LIABILITIES

49,107

44,016

PROVISIONS FOR LIABILITIES (200 ) (243 )
NET ASSETS 48,907 43,773

CAPITAL AND RESERVES
Called up share capital 8 125 125
Retained earnings 48,782 43,648
SHAREHOLDERS' FUNDS 48,907 43,773

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937)

BALANCE SHEET - continued
31 DECEMBER 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 October 2023 and were signed on its behalf by:





Dr K G Syal - Director


GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022


1. STATUTORY INFORMATION

Glan yr Afon Surgery Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is Pound Sterling (£).

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis, which assumes the continuing support of the company's directors, bankers and other creditors. The directors believe that this support will continue and are satisfied that the company is a going concern.

TURNOVER
Turnover represents amounts receivable for services provided.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost and 15% on cost

Tangible fixed assets are initially measured at cost. After initial recognition, tangible fixed assets are measured at cost less any accumulated depreciation and any accumulated impairment losses.

FINANCIAL INSTRUMENTS
Financial instruments are initially measured at fair value on the date on which it is entered into and are subsequently measured at fair value through profit or loss.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2022


2. ACCOUNTING POLICIES - continued

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
An NHS superannuation pension scheme is operated. Superannuation contributions payable to the scheme are charged to the profit and loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 16 (2021 - 14 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2022
and 31 December 2022 9,599
DEPRECIATION
At 1 January 2022 8,317
Charge for year 226
At 31 December 2022 8,543
NET BOOK VALUE
At 31 December 2022 1,056
At 31 December 2021 1,282

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade debtors 73,187 78,416
Other debtors 14,337 4,698
87,524 83,114

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade creditors 52,783 (3,688 )
Taxation and social security 97,683 101,747
Other creditors - 29,299
150,466 127,358

7. FINANCIAL INSTRUMENTS

Barclays Bank PLC hold a fixed and floating charge (0770 0937 0001) on all property of the company in respect of a debenture issued 15 May 2013.

GLAN YR AFON SURGERY LTD (REGISTERED NUMBER: 07700937)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2022


8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2022 2021
value: £    £   
50 ordinary A shares 1 50 50
50 ordinary D shares 1 50 50
25 ordinary E shares 1 25 25
125 125

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

During the year, the following material transactions with Directors took place:

Dr K G Syal

£
Due to director at 1 January 2022-
Drawn from the company during the year to 31 December 2022(184,792)
Repaid to the company during the year to 31 December 20227,542
Dividends declared177,250
Due to director at 31 December 2022-


Dr G Mathews

£
Due to director at 1 January 2022-
Drawn from the company during the year to 31 December 2022(168,098)
Repaid to the company during the year to 31 December 2022 10,119
Dividends declared157,979
Due to director at 31 December 2022-

Dr A Samarasinghe

£
Due to director at 1 January 2022-
Drawn from the company during the year to 31 December 2022(75,570)
Dividends declared75,570
Due to director at 31 December 2022-